Hermes Biosciences is Drug Delivery in United States that focus on developer business. Founded in 1998. They cover business area such as developer, target drug delivery technology, therapeutic and other biomedical application, integration, nanosized liposome, cell-target antibody-base ligand, lipid-base nanocarrier system, an array, small molecule drug, probe, macromolecular agent, nucleic acid therapeutic.
1998
( 26 years old in 2024 )
Developer
-
61 Airport Boulevard
Suite D
South San Francisco, CA 94080
United States
Private
developertarget drug delivery technologytherapeutic and other biomedical applicationintegrationnanosized liposomecell-target antibody-base ligandlipid-base nanocarrier systeman arraysmall molecule drugprobemacromolecular agentnucleic acid therapeutic
* We use standard office opening hours in near Hermes Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Hermes Biosciences is Drug Delivery business from United States that founded in 1998 (26 years old in 2024), Hermes Biosciences business is focusing on Developer.
Hermes Biosciences headquarter office and corporate office address is located in 61 Airport Boulevard Suite D South San Francisco, CA 94080 United States.
Hermes Biosciences was founded in United States.
In 2024, Hermes Biosciences is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Hermes Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
